13F Pro

SEC Form 4 reporting owner

Dier Mardi

Dier Mardi has filed 23 Form 4 transactions reported between December 2, 2025 and March 6, 2026, as EVP and CFO of MADRIGAL PHARMACEUTICALS, INC. and a reporting owner of Oric Pharmaceuticals, Inc..

Name as filed: Dier Mardi

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$3.0M
19 lines
Companies
2
with Form 4 filings
Latest transaction
Mar 6, 2026
transaction date

Roles and reported holdings

  • MDGLMADRIGAL PHARMACEUTICALS, INC.
    Dec 2, 2025 – Mar 6, 2026

    EVP and CFO

    Held directly12,850 sh as of Mar 6, 2026 · Form 4

    24 months: $3.0M sold

  • ORICOric Pharmaceuticals, Inc.
    Jan 2, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 23 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Mar 6, 2026MDGLEVP and CFOOpen-market saleCode S · direct116$50K@ $432.56Form 4
Mar 6, 2026MDGLEVP and CFOOpen-market saleCode S · direct120$52K@ $430.90Form 4
Mar 6, 2026MDGLEVP and CFOOpen-market saleCode S · direct160$69K@ $429.00Form 4
Mar 6, 2026MDGLEVP and CFOOpen-market saleCode S · direct80$34K@ $427.85Form 4
Mar 6, 2026MDGLEVP and CFOOpen-market saleCode S · direct420$179K@ $426.86Form 4
Mar 6, 2026MDGLEVP and CFOOpen-market saleCode S · direct40$17K@ $425.08Form 4
Mar 6, 2026MDGLEVP and CFOOpen-market saleCode S · direct646$279K@ $431.94Form 4
Mar 4, 2026MDGLEVP and CFOGrant or awardCode A · direct6,519—Form 4
Mar 4, 2026MDGLEVP and CFOGrant or awardCode A · direct5,215—Form 4
Mar 2, 2026MDGLEVP and CFOOpen-market saleCode S · direct1,183$505K@ $427.21Form 4
Jan 2, 2026ORICGrant or awardCode A · direct40,000—Form 4
Dec 2, 2025MDGLEVP and CFOOpen-market saleCode S · direct80$48K@ $596.18Form 4
Dec 2, 2025MDGLEVP and CFOOpen-market saleCode S · direct74$44K@ $595.20Form 4
Dec 2, 2025MDGLEVP and CFOOpen-market saleCode S · direct160$94K@ $589.65Form 4
Dec 2, 2025MDGLEVP and CFOOpen-market saleCode S · direct480$278K@ $579.85Form 4
Dec 2, 2025MDGLEVP and CFOOpen-market saleCode S · direct258$149K@ $578.83Form 4
Dec 2, 2025MDGLEVP and CFOOpen-market saleCode S · direct240$138K@ $576.15Form 4
Dec 2, 2025MDGLEVP and CFOOpen-market saleCode S · direct120$69K@ $574.95Form 4
Dec 2, 2025MDGLEVP and CFOOpen-market saleCode S · direct717$412K@ $574.00Form 4
Dec 2, 2025MDGLEVP and CFOOpen-market saleCode S · direct354$203K@ $573.02Form 4
Dec 2, 2025MDGLEVP and CFOOpen-market saleCode S · direct410$235K@ $571.99Form 4
Dec 2, 2025MDGLEVP and CFOOpen-market saleCode S · direct320$183K@ $570.39Form 4
Dec 2, 2025MDGLEVP and CFOOption exerciseCode M · direct4,173$1.1M@ $251.63Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.